1-methyl-4-phenyl-2,3-dihydropyridinium has been researched along with ubiquinone in 1 studies
Studies (1-methyl-4-phenyl-2,3-dihydropyridinium) | Trials (1-methyl-4-phenyl-2,3-dihydropyridinium) | Recent Studies (post-2010) (1-methyl-4-phenyl-2,3-dihydropyridinium) | Studies (ubiquinone) | Trials (ubiquinone) | Recent Studies (post-2010) (ubiquinone) |
---|---|---|---|---|---|
46 | 0 | 3 | 9,497 | 597 | 3,655 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Niki, E; Noguchi, N; Shi, H; Xu, Y | 1 |
1 other study(ies) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and ubiquinone
Article | Year |
---|---|
1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biotransformation; Liposomes; Male; Monoamine Oxidase; Neurotoxins; Oxidation-Reduction; Pyridinium Compounds; Rats; Rats, Wistar; Synaptosomes; Ubiquinone | 1999 |